Nanomedicine and Nanoscale Delivery (Focus Group – NND)

Ana F. Bettencourt, PharmD, PhD (she/her/hers)
Professor
Faculdade de Farmacia, Universidade de Lisboa
Lisboa, Lisboa, Portugal
Periodontal and peri-implant diseases (PDPIs) are chronic inflammatory conditions driven by dysbiotic biofilms and an exacerbated host immune response, leading to tissue destruction and implant failure (1). Conventional therapies often fail to adequately control inflammation, highlighting the need for local immunomodulatory strategies. In this context, this study aims to develop zinc–magnesium layered hydroxide nanoparticles loaded with rosehip, a phytochemical anti-inflammatory bioactive (2), as a nanotechnology-based platform for localized immunomodulation in PDPIs.